The Urology Group
Press / In The News /
September 20, 2017

NKY Tribune - Immunotherapy Treatment

Drs. Gary Kirsh and Brooke Edwards share hopeful news for African Americans facing advanced prostate cancer​. An FDA-approved immunotheraphy has been shown to provide additional overall survival benefit of 9.3 months for African-American men with advanced prostate cancer. 

Click here to read full article. 

 

Get the latest news about The Urology Group:

Patient Help Center

PATIENT FORMSPATIENT PORTALPAY ONLINEFIND AN OFFICEPHARMACY SERVICES

IN THE NEWS BLOG PRESS RELEASES
  • The Urology Group named a Center of Excellence by NAFC
    February 13, 2019
    The Urology Group was recently designated a Center of Excellence by the National Association for Continence. The COE designation is based on evidence of training, clinical experience, resources and patient satisfaction statistics that meet established standards. These rigorous standards ensure that each center that is designated a COE is truly exceptional at providing care for patients with pelvic floor dysfunction and incontinence. MORE...